Pharmacopeia, Inc. (ACCL) (Prev: PCOP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP)

ACCL 4.050

-8.0%

3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (132)	1/19/1999 1:28:00 PM
From: kinkblot	of 179

Pharmacopeia and Pharmacia & Upjohn Form Research Collaboration: PRINCETON, NJ (January 19, 1999) - Pharmacopeia, Inc. (Nasdaq: PCOP) today announced the signing of a new multi-year, multi-target research collaboration with Pharmacia & Upjohn Inc. Under the terms of the agreement, Pharmacopeia will screen its multi-million compound sample collection of diverse, small molecules against numerous targets chosen by Pharmacia & Upjohn each year. In addition to annual guaranteed payments, Pharmacia & Upjohn will make further payments based on the success of the screening programs. Optimization of active compounds identified by Pharmacopeia may be performed either by Pharmacia & Upjohn or by Pharmacopeia, for additional consideration. Financial terms of the agreement were not disclosed. ...[continued] pharmacopeia.com .................... At least the stock responded positively this time. Maybe their stockpile of molecules is finally approaching 'critical mass'.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next